Published in Pediatr Nephrol on October 17, 2007
Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes. Diabetes (2015) 1.44
Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care (2013) 1.31
Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial. J Diabetes Complications (2014) 0.90
Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatr Nephrol (2008) 0.85
Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag (2009) 0.83
The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood. Pediatr Nephrol (2011) 0.81
Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation. Physiol Rep (2014) 0.79
Nephropathy in youth and young adults with type 2 diabetes. Curr Diab Rep (2014) 0.79
Regression and progression of microalbuminuria in adolescents with childhood onset diabetes mellitus. Ann Pediatr Endocrinol Metab (2015) 0.76
HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study. BMC Nephrol (2016) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med (2001) 10.36
Lifetime risk for diabetes mellitus in the United States. JAMA (2003) 10.33
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care (2005) 9.97
Standards of medical care in diabetes--2006. Diabetes Care (2006) 9.56
Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA (1999) 9.46
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis (2007) 8.79
Regression of microalbuminuria in type 1 diabetes. N Engl J Med (2003) 7.67
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (1982) 6.93
Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med (2006) 6.71
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA (2002) 6.61
Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care (2000) 6.21
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int (2003) 5.37
The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes (1996) 5.09
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia (1983) 4.48
Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med (1989) 4.40
Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int (1995) 4.35
Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care (2005) 4.13
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med (1995) 3.76
Emerging epidemic of type 2 diabetes in youth. Diabetes Care (1999) 3.74
Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes (1999) 3.68
Type 1 diabetes. Lancet (2006) 3.61
Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care (2006) 3.16
The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med (1996) 3.15
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care (2003) 3.12
Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes (1990) 3.07
The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes (2002) 3.00
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr (2001) 2.98
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int (2002) 2.92
Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1990) 2.81
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis (1994) 2.69
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ (2004) 2.62
The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes (1983) 2.56
Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia (1996) 2.53
Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia (1984) 2.50
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes (2000) 2.41
Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes (1997) 2.33
Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes. Diabetes Care (1997) 2.27
Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol (2005) 2.18
Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes (2003) 2.16
Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care (2004) 2.13
Childhood obesity and type 2 diabetes mellitus. Pediatrics (2005) 2.08
Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA (2006) 2.07
Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet (2007) 2.01
A genome scan for diabetic nephropathy in African Americans. Kidney Int (2004) 2.00
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia (1996) 1.98
Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet (1993) 1.95
Does microalbuminuria predict diabetic nephropathy? Diabetes Care (2001) 1.93
Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study. Diabetologia (2004) 1.92
Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int (2006) 1.91
Association of obesity with physical activity, television programs and other forms of video viewing among children in Mexico city. Int J Obes Relat Metab Disord (1999) 1.83
The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes (2002) 1.79
The natural history of microalbuminuria in adolescents with type 1 diabetes. J Pediatr (1999) 1.72
Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med (1994) 1.69
Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care (2003) 1.68
Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest (1986) 1.67
The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67
Is microalbuminuria progressive? Arch Dis Child (1995) 1.66
Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia (2004) 1.64
Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes (1989) 1.64
Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int (2002) 1.62
Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med (1998) 1.61
Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis (2006) 1.59
Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol (1993) 1.59
Borderline increases in albumin excretion rate and the relation to glycemic control in subjects with type I diabetes. Clin Chem (1991) 1.58
Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Nephrol (2006) 1.56
Alterations of blood pressure in type 1 diabetic children and adolescents. Pediatr Nephrol (2006) 1.56
Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med (2001) 1.55
Diabetic nephropathy: a risk factor for diabetes mellitus in offspring. Diabetologia (1995) 1.54
Kidney function during and after withdrawal of long-term irbesartan treatment in patients with type 2 diabetes and microalbuminuria. Diabetes Care (2003) 1.51
Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care (2003) 1.46
Progression of diabetic nephropathy. Kidney Int (2001) 1.46
Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes (1998) 1.45
Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care (1999) 1.44
Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care (2003) 1.41
Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 1.41
The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes (2005) 1.40
Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes (1988) 1.40
The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int (2005) 1.40
ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications. Pediatr Diabetes (2007) 1.39
Intermittent microalbuminuria in children with type 1 diabetes mellitus without clinical evidence of nephropathy. Eur J Pediatr (1988) 1.39
Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group. Diabet Med (1999) 1.38
Renal function in diabetes mellitus. Arch Dis Child (1985) 1.34